HCPCS code Q9997 — Ustekinumab-ttwe iv inj 1 mg.
Status: Active.
Effective Jan 1, 2025.
Source: CMS HCPCS Level II.
Q9997
ActiveUstekinumab-ttwe iv inj 1 mg
Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
Category:
Temporary
Section:
Q-codes: Temporary Codes
Effective:
Jan 1, 2025
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
0914
MUE — Medically Unlikely Edits
Maximum units of Q9997 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 520 |
| Outpatient Hospital | 520 |
| Practitioner Services | 520 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 61314-0654-94 | Pyzchiva |
| 82009-0163-94 | Pyzchiva |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2025-Q1Ustekinumab-ttwe iv inj 1 mg